Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 400803Generated: October 26, 2026

5-tert-Butyl-3-(2-chloro-benzyl)-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidine → 5-tert-Butyl-3-(2-chloro-benzyl)-7-(3-methoxy-azetidin-1-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine

https://huagongshe.com/reaction/400803

Reaction equation

Participants

RoleNameHCIDCharge
Reactant5-tert-Butyl-3-(2-chloro-benzyl)-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidineHCID 1433953—
Reactant3-Methoxyazetidine hydrochlorideHCID 22242858—
Reactant5-tert-butyl-7-chloro-3-(2-chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidineHCID 86683284—
Product5-tert-Butyl-3-(2-chloro-benzyl)-7-(3-methoxy-azetidin-1-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidineHCID 71557239—

Reaction Steps

In analogy to the procedure described for the synthesis of 5-tert-butyl-3-(2-chloro-benzyl)-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (example 1, step c), the title compound was prepared from 5-tert-butyl-7-chloro-3-(2-chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine and 3-methoxyazetidine hydrochloride and isolated as white solid (11.0 mg, 60%). MS (m/e): 387.4 (MH+).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08741906B2
Source datasetuspto-grants-2014_06
ORD IDord-c1bac94cd4d3441d9de68d6ef6c86bf1
Source noteuspto-grants-2014_06